Journals / Viral Hepatitis Journal / 2013 / Cilt: 19 - Sayı: 3

Hepatic Steatosis in Inactive Hepatitis B Carriers: Prevalence, Evaluation of Viral and Biochemical Parameters

İnaktif Hepatit B Taşıyıcılarında Hepatosteatoz: Sıklığı, Biyokimyasal ve Viral Parametrelerin Değerlendirilmesi

Pages
144–147
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Negative correlation between viral load and steatosis may suggest a protective effect of viral replication against to hepatic steatosis, but further studies are needed.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Hepatic steatosis is defined as the amount of fat is more than 5% of liver weight.
📊
Key Findings & Data:Materials and Methods: The freuquency of hepatosteatosis was investigated using abdominal ultrasonography in the patients who admitted to the outpatient clinic of the infectious diseases department between July 2012 and October 2013, and diagnosed as hepatitis B carrier.
💡
Conclusion & Impact:Negative correlation between viral load and steatosis may suggest a protective effect of viral replication against to hepatic steatosis, but further studies are needed.
🔬Design:Research Article
📍Scope:2012 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: Hepatic steatosis is defined as the amount of fat is more than 5% of liver weight. The aim of this study was to evaluate prevalence of hepatic steatosis, evaluation of viral and biochemical parameters in inactive hepatitis B carriers. Materials and Methods: The freuquency of hepatosteatosis was investigated using abdominal ultrasonography in the patients who admitted to the outpatient clinic of the infectious diseases department between July 2012 and October 2013, and diagnosed as hepatitis B carrier. The patients who were HBsAg positive, had HBV DNA below 2000 IU/mL, and were anti-delta and anti-HCV negative diagnosed as carrier. PASW (ver. 18) software system was used in statistical analysis. Results: Three hundred forty inactive hepatitis B carriers enrolled the study. Based on abdominal ultrasound findings hepatic steatosis detected in 177 (52%) patients. There were statistically significances in the patients with steatosis in terms of older age, GGT, TG and total cholesterol levels compared to the patients without steatosis ( p<0.05). There were no significant differences between the groups in terms of AST, ALP, LDH levels (p>0.05). HBV DNA level of the patients without steatosis was significantly higher when we compared to those with steatosis (p=0.009). Conclusion: Hyperlipidemia, elevation of GGT levels were associated with hepatic steatosis in inactive HBV carriers. Negative correlation between viral load and steatosis may suggest a protective effect of viral replication against to hepatic steatosis, but further studies are needed.

Özet

Amaç: Hepatosteatoz karaciğerde yağ miktarının, karaciğer ağırlığının %5’inden fazla olması olarak tanımlanır. Bu çalışmanın amacı inaktif hepatit B taşıyıcısı tanısıyla izlediğimiz hastalarda hepatosteatoz sıklığının, viral ve biyokimyasal parametrelerin değerlendirilmesidir. Gereç ve Yöntemler: Temmuz 2012-Ekim 2013 tarihleri arasında enfeksiyon hastalıkları polikliniğine müraacat eden, inaktif hepatit B taşıyıcısı teşhisi almış olan hastalarda, abdominal ultrasonografi ile hepatosteatoz sıklığı araştırılmıştır. HBsAg’si pozitif, HBV-DNA’sı 2000 IU/mL’nin altında, anti-delta ve anti-HCV’si negatif olan hastalar inaktif hepatit B taşıyıcısı olarak kabul edilmiştir. İstatistiksel hesaplamalarda PASW (ver. 18) programı kullanılmıştır. Bulgular: Çalışmaya 340 inaktif hepatit B taşıyıcısı dahil edildi. Abdominal ultrasonografi bulgularına bakıldığında 177 (%52) hastada hepatik steatoz saptandı. Steatozu olanlarda yaş, GGT, TG ve total kolesterol değerlerinin ortalaması steatozu olmayanlara göre anlamlı düzeyde yüksekti (p 0,05). HBV DNA ortalaması ise steatozu olmayan grupta anlamlı düzeyde yüksekti (p=0,009). Sonuç: Hepatosteatoz inaktif HBV taşıyıcılarında hiperlipidemi ve GGT seviyelerindeki yükseklik ile ilişkili bulunmuştur. Viral yük ile steatoz arasındaki negatif korelasyon viral replikasyonun hepatosteatoza karşı koruyucu bir etkisi olabileceğini düşündürmektedir, ancak bu konuda daha ileri çalışmalara ihtiyaç vardır.

🔖

Cite This Article

KORKMAZ, P., AYKIN, N., ÇEVİK, F. Ç., ALPAY, Y., NAZ, H., GÜLDÜREN, H. M. (2013). Hepatic Steatosis in Inactive Hepatitis B Carriers: Prevalence, Evaluation of Viral and Biochemical Parameters. Viral Hepatitis Journal, Cilt: 19 - Sayı: 3, 144–147. https://ajindex.com/articles/332750

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Vere CC, Neagoe D, Streba CT, Prejbeanu I, Ianoşi G, Comă nescu V. et al. Steatosis and serum lipid patterns in patints with chronic viral hepatitis:differences related to viral etiology. Romanian Journal of Morphology and Embryology. 2010; 51(3): 509-14
  2. Rubbia-Brandt L, Quadri R, Abid K, Giostra E, Malé PJ, Mentha G, et al. Hepatocyte steatosis is a cytopathic effect of hepatitis C virus genotype 3, J Hepatol, 2000; 33(1): 106-15
  3. Sanyal AJ, Contos MJ, Sterling RK, Luketic VA, Shiffman ML, Stravitz RT, et al. Nonalcoholic fatty liver disease in patients with hepatitis C is associated wih features of the metabolic syndrome. Am. J.Gastroenteorol. 2003; 98: 2064-71
  4. Mohammad Alizadeh AH, Fallahian F, Alavian SM, Ranjbar M, Hedayati M, Rahimi F, et al. Insülin resistance in chronic hepatitis B and C. Indian J. Gastroenterol. 2006;25: 286-9
  5. Angulo P. Nonalcoholic fatty liver disease. Rev Gastroenterol Mex. 2005; 70(Suppl 3): 52-6
  6. Chinese Society of Hepatology, Chinese Society of Infectious Diseases. The Guideline of prevention and treatment for chronic hepatitis B.Chin Prev Med. 2011; 12:1-15
  7. European Association For The Study Of The Liver. EASL clinical practice guidelines: Management of chronic hepatitis B virus infection. J Hepatol. 2012; 50(2): 227-42
  8. Zheng R, Chen J, Zhuang Q, Lu Y, Chen J, Chen B. Clinical and virological characteristics of chronic hepatitis B patients with hepatic steatosis.Int. J. of Med. Sci. 2013; 10(5): 611-46
  9. Bondini S,Younossi ZM. Non-alcoholic fatty liver disease and hepatitis C infection. Minerva Gastroenterol Dietol, 2006; 52: 135-43
  10. Hou XH, Zhu YX, Lu HJ, Chen HF, Li Q, Jiang S, et al. Non- alcoholic fatty liver disease’s prevalence and impact on alanine aminotransferase associated with metabolic syndrome in the Chinese. J Gastroenterol Hepatol. 2011; 26: 722-30
  11. Thomopoulos KC, Arvaniti V, Tsamantas AC, Dimitropoulou D, Gogos CA, Siagris D, et al. Prevalence of liver steatosis in patients with chronic hepatitis B:a study of associated factors and relationship with fibrosis. Eur. J. Gastroenterol. Hepatol. 2006; 18: 233-7
  12. Altlparmak E, Koklu S, Yalinkilic M, Yuksel O, Cicek B, Kayacetin E, et al. Viral and host causes of fatty liver in chronic hepatitis B. World J Gastroenterol. 2005; 11(20): 3056-9
  13. Bondini S, Kallman J, Wheeler A, Prakash S, Gramlich T, Jondle DM, et al. Impact of non-alcoholic fatty liver disease on chronic hepatitis B. Liver Int. 2007; 27: 607-11